Back

High plasma levels of soluble LOX-1 portends poor survival in acute coronary syndromes beyond GRACE 2.0: A multicentre prospective cohort study

27 August 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Coronary Artery Disease (Chronic)/Chronic Coronary Syndromes ePosters Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Simon Kraler

Bern University Hospital, Inselspital, Bern (Switzerland)

178 More presentations in this session

Presentation thumbnail
The quest for GRACE 3.0: improving our beloved risk score with machine learning
Doctor J. Sousa (Porto, PT)
Abstract Slides
Presentation thumbnail
Percutaneous coronary interventions in patients with left main coronary artery pseudobifurcation lesions: 5-years follow-up
Associate Professor D. Maximkin (Moscow, RU)
Abstract Slides
Presentation thumbnail
Use of intima media thickness in the assessment of the development of preclinical atherosclerosis
Associate Professor R. Najafov (Baku, AZ)
Abstract Slides
Presentation thumbnail
Long term outcomes of patients with chronic inflammatory diseases after percutaneous coronary intervention
Doctor O. Kobo (Hadera, IL)
Abstract Slides
Presentation thumbnail
Feasibility, safety and long term outcomes of complex left main bifurcation treatment using the nano inverted t stenting: a multicentre registry
Associate Professor G. Rigatelli (Rovigo, IT)
Abstract Slides

Access the full session

Session thumbnail
Coronary Artery Disease (Chronic)/Chronic Coronary Syndromes ePosters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Soluble LOX-1 (lectin-type oxidized LDL receptor 1) is associated with inflammation and mortality in aortic valve stenosis
31 August 2025
thumbnail
Congress Presentation
The value of GRACE risk score for predicting mortality in heart failure patients admitted with Non ST elevation Acute Coronary Syndrome
29 June 2021
thumbnail
Congress Presentation
LDL-cholesterol levels post-acute coronary syndrome: 24-months variation
4 April 2025
thumbnail
Congress Presentation
Novel platelet-to-lymphocyte and glucose-to-lymphocyte ratios as prognostic markers in acute coronary syndrome
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources